Navigation Links
Transdel Pharmaceuticals Announces Exploration of Strategic Alternatives
Date:2/1/2011

LA JOLLA, Calif., Feb. 1, 2011 /PRNewswire/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced that the Company has been exploring strategic alternatives aimed at enhancing shareholder value with two investment banks, American MedTech Advisors and ESC Advisors, a division of KEMA Partners.  The goal of this engagement is to continue further development of TDLP-110 (aka Ketotransdel®), the Company's lead late stage pain product.

Transdel has completed the first Phase 3 trial for TDLP-110, and has presented the key data in support of efficacy and safety at the 13th World Congress on Pain in Montreal, Canada, in September 2010.  The Company believes that TDLP-110 has an opportunity to be the first topical ketoprofen product approved in the U.S. and also to become a 'best in class' product in the growing topical NSAID market.

Strategic alternatives the Company may pursue could include, but are not limited to, partnering or other collaboration agreements, a merger, a equity or debt financing, sale of the Company or other strategic transactions.  There can be no assurance that the exploration of strategic alternatives will result in any agreements or transactions, or that, if completed, any agreements or transactions will be successful or on attractive terms. The Company does not intend to disclose developments with respect to this process unless and until the evaluation of strategic alternatives has been completed or the board of directors has approved a specific transaction.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, any securities of the Company, prior to the registration or qualification for
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
2. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
3. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
4. Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference
5. Transdel Pharmaceuticals Announces Management Reorganization
6. Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
7. Transdel Pharmaceuticals Appoints John N. Bonfiglio, Ph.D. as Chief Executive Officer and President
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... MELVILLE, N.Y. , Sept. 16, 2014 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, announced today that Stanley M. ... Officer, will participate in a healthcare services panel ... 2014.  Joining Mr. Bergman will be Dr. Stohler, ...
(Date:9/16/2014)... 16, 2014  Eli Lilly and Company (NYSE: ... an agreement to co-develop and commercialize AZD3293, an ... in development as a potential treatment for Alzheimer,s ... is characterized by the accumulation of amyloid plaque ... with the development of beta-amyloid. Inhibiting BACE is ...
(Date:9/16/2014)... , N.J. and NEW PROVIDENCE, N.J. , ... experts will present a paper on the critical elements ... oxygen storage and deliver systems at the American Society ... be held at the Chicago Sheraton Hotel and Towers ... Derrick West , program manager of Hospital ...
Breaking Medicine Technology:Henry Schein To Present At The Leerink Partners Services Roundtable 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 2Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 3
... LAKE FOREST, Ill. , Jan. 22 Hospira, ... and medication delivery company, and its philanthropic arm, the Hospira Foundation, ... medical products and cash grants to support humanitarian relief efforts in ... at more than $1.5 million , are either in ...
... SOMERVILLE, N.J. , Jan. 20 ... acquisition of Acclarent, Inc., following clearance under the Hart-Scott-Rodino ... technology company dedicated to designing, developing and commercializing devices ... (ENT). Ethicon announced its agreement to acquire Acclarent ...
Cached Medicine Technology:Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants 2
(Date:9/16/2014)... 16, 2014 AxoGen, Inc. ... the peripheral nerve repair market, announced that it will ... Surgery of the Hand (ASSH) 2014 Annual Meeting, taking ... Center in Boston, MA. , The event, entitled “Nerve ... repair, featuring a discussion by leading nerve repair experts ...
(Date:9/16/2014)... Grants Pass, OR (PRWEB) September 16, 2014 ... PhD, is experiencing a major extended drought crisis that ... basic survival. Grigg praises the many individuals who are ... many fresh water policy solutions overlook large portion of ... creating new, possibly worse crises.     , Grigg explained his, ...
(Date:9/16/2014)... Beverly Hills, CA (PRWEB) September 16, 2014 ... to announce the launch of ACLsurgeryLA.com , a ... various ACL injuries. As an avid sports lover ... best options for treatment and recovery from injuries to ... this opportunity to offer patients a resource dedicated specifically ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Registration is ... For The Warriors®, a 10K, 5K, and 1-mile walk/run ... race is sponsored by Local 338 RWDSU/UFCW, the Town ... begin at the Town of Babylon Town Hall in ... http://www.hopeforthewarriors.org/2014LIRun . The run is organized by Hope For ...
(Date:9/16/2014)... Birmingham, Alabama (PRWEB) September 16, 2014 *To ... Birmingham, AL, visit Achieve Clinical Research on the web ( ... For those who qualify:, There is ... required , Compensation may be provided for ... stands, pneumonia and influenza are the eighth leading cause of ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. to Host Surgeon Education Event at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. to Host Surgeon Education Event at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:Drought Solutions Overlook Too Many Factors Water Policy Expert Warns Sharon Kleyne 2Health News:Drought Solutions Overlook Too Many Factors Water Policy Expert Warns Sharon Kleyne 3Health News:Los Angeles Orthopedic Surgeon Spotlights ACL Conditions With New Website 2Health News:Los Angeles Orthopedic Surgeon Spotlights ACL Conditions With New Website 3Health News:The Hope For The Warriors Long Island Run For The Warriors to Honor Wounded and Families of the Fallen 2Health News:The Team at Achieve Clinical Research is Enrolling Qualified Individuals to Participate in a Pneumonia Vaccine Clinical Trial in Birmingham, Alabama 2Health News:The Team at Achieve Clinical Research is Enrolling Qualified Individuals to Participate in a Pneumonia Vaccine Clinical Trial in Birmingham, Alabama 3
... , Briefing is the second in ... , WASHINGTON, Sept. 14 The Council ... Hill titled "Translational Research - From Bench to Bedside." Health policy ... development and approval for safe and effective drugs, biologics, medical devices ...
... /PRNewswire-FirstCall/ - SXC Health Solutions Corp. ("SXC" or the ... announced it has entered into a strategic relationship with ... electronic prescribing (e-prescribing) options available to SXC,s healthcare benefits ... - health plans, employers, government agencies, pharmacy benefit managers ...
... drug therapy often doesn,t reach the right patients, study ... research suggests that the anti-breast cancer drug trastuzumab, also ... patients aren,t receiving tests that determine whether it,s appropriate ... , Under current guidelines, women with breast cancer ...
... , Desperate Housewives, Star Joins The Wellness Community ... , , PHILADELPHIA, Sept. 14 /PRNewswire-USNewswire/ ... Desperate Housewives , found himself in a role he hoped ... of his two sisters in late 2008 left Chavira shocked and ...
... , , , ... Conference(TM), an interactive forum to discuss the regulatory and operational ... trial process where improvements can be made. Scheduled for October ... lectures, interactive workshops, and panel discussions on topics that challenge ...
... , WEST PALM BEACH, Fla., Sept. ... Bootcamp University program in New York (Oct 10th) is ... for the New York program, this is a reflection ... fills. Designed for residents and fellows in core esthetic ...
Cached Medicine News:Health News:'Translational Research: From Bench to Bedside' Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 2Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 2Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 3Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 4Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 5Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 2Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 3Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 4Health News:NCCN Holds Oncology Research Best Practices Conference 2Health News:NCCN Holds Oncology Research Best Practices Conference 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Signature is ... microbial detection system that integrates blood, ... It is a powerful microbiology workstation ... for higher volume identification and where ...
Medicine Products: